U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
SM101
Preferred Name English
VALZIFLOCEPT
INN   USAN  
Official Name English
SM-101
Code English
SHP652
Code English
FC.GAMMA.RIIB RECEPTOR (HUMAN SOLUBLE EXTRACELLULAR FRAGMENT)
Common Name English
RECOMBINANT HUMAN SOLUBLE FC-GAMMA RECEPTOR IIB
Common Name English
RECOMBINANT, SOLUBLE, NON-GLYCOSYLATED VERSION OF FC GAMMA RECEPTOR IIB
Common Name English
VALZIFLOCEPT [USAN]
Common Name English
SHP-652
Code English
HUMAN IMMUNOGLOBULIN GAMMA FC REGION RECEPTOR II-B (FC.GAMMA.RII-B), EXTRACELLULAR N-TERMINAL FRAGMENT, PRODUCED IN ESCHERICHIA COLI
Common Name English
Valziflocept [WHO-DD]
Common Name English
valziflocept [INN]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 287709
Created by admin on Tue Apr 01 21:38:16 GMT 2025 , Edited by admin on Tue Apr 01 21:38:16 GMT 2025
NCI_THESAURUS C308
Created by admin on Tue Apr 01 21:38:16 GMT 2025 , Edited by admin on Tue Apr 01 21:38:16 GMT 2025
EU-Orphan Drug EU/3/07/462
Created by admin on Tue Apr 01 21:38:16 GMT 2025 , Edited by admin on Tue Apr 01 21:38:16 GMT 2025
Code System Code Type Description
CAS
1804910-11-9
Created by admin on Tue Apr 01 21:38:16 GMT 2025 , Edited by admin on Tue Apr 01 21:38:16 GMT 2025
PRIMARY
USAN
EF-112
Created by admin on Tue Apr 01 21:38:16 GMT 2025 , Edited by admin on Tue Apr 01 21:38:16 GMT 2025
PRIMARY
FDA UNII
EA2075XV4Y
Created by admin on Tue Apr 01 21:38:16 GMT 2025 , Edited by admin on Tue Apr 01 21:38:16 GMT 2025
PRIMARY
NCI_THESAURUS
C152824
Created by admin on Tue Apr 01 21:38:16 GMT 2025 , Edited by admin on Tue Apr 01 21:38:16 GMT 2025
PRIMARY
SMS_ID
300000005302
Created by admin on Tue Apr 01 21:38:16 GMT 2025 , Edited by admin on Tue Apr 01 21:38:16 GMT 2025
PRIMARY
INN
10457
Created by admin on Tue Apr 01 21:38:16 GMT 2025 , Edited by admin on Tue Apr 01 21:38:16 GMT 2025
PRIMARY
ACTIVE MOIETY
VALZIFLOCEPT
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966